Serial #79168971
DEAD

Serial Number

79168971

Owner

Circassia Limited

Attorney

Bryce J. Maynard

Filing Date

Dec 17, 2014

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79168971 Trademark

Serial Number: 79168971 • Registration: 4975416

Serial #79168971 is a trademark filed by Circassia Limited on December 17, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Circassia Limited (11 trademarks)

Northbrook House, Robert Robinson Avenue,

Entity Type: 99

Trademark Details

Filing Date

December 17, 2014

Registration Date

June 14, 2016

Published for Opposition

March 29, 2016

Cancellation Date

December 17, 2024

Goods & Services

Pharmaceutical and veterinary preparations for the testing, diagnosis, prevention or treatment of drug dependency, substance addiction, poisoning, overdose, envenomation, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders

Scientific research for medical purposes in the fields of allergies, drug dependency, substance addiction, autoimmune disease, poisoning, overdose, envenomation transplant rejection, immunodeficiency disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders; medical and pharmacological research services in the fields of allergies, drug dependency, substance addiction, autoimmune disease, poisoning, overdose, envenomation, transplant rejection, immunodeficiency disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the fields of pharmaceutical and clinical trials; conducting clinical trials for others; information, advisory and consultancy services relating to the aforesaid

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 11, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jul 11, 2025 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Oct 9, 2023 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 16, 2023 INTS
INVALIDATION PROCESSED
Sep 16, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 30, 2023 INTR
CANCELLED SECTION 71
Dec 30, 2022 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Dec 4, 2021 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 14, 2021 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 25, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 13, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 19, 2016 FICS
FINAL DISPOSITION PROCESSED
Sep 19, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 14, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 14, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 29, 2016 NPUB
PUBLISHED FOR OPPOSITION
Mar 29, 2016 PUBO
NOTIFICATION PROCESSED BY IB
Mar 25, 2016 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 9, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 9, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 9, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 23, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 4, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 4, 2016 TROA
REFUSAL PROCESSED BY IB
Aug 22, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 4, 2015 RFCS
REFUSAL PROCESSED BY MPU
Aug 4, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 4, 2015 RFCR
NON-FINAL ACTION WRITTEN
Aug 3, 2015 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 31, 2015 MAFR
ASSIGNED TO EXAMINER
Jul 27, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 27, 2015 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 22, 2015 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 16, 2015 REPR